Effect of sex and menstrual cycle in women on starting speed, anaerobic endurance and muscle power

The aim of our study was to compare the indicators of starting speed, anaerobic endurance and power in women as well as men, and to investigate whether the values of these indicators differ in women during the follicular and luteal phases of the menstrual cycle. The studied group included 16 men and 16 women. The subjects performed the 20-second maximal cycling sprint test. The men performed the test twice at 14-day intervals. The women undertook the test 4 times: twice during the middle of follicular phase and twice in the middle of luteal phase in separate menstrual cycles. Hormonal changes during the menstrual cycle do not influence anaerobic performance, starting speed or anaerobic endurance in women. Anaerobic performance in men is higher than in women with similar aerobic performance expressed as VO2max/LBM (lean body mass). A lower power decrease with time was noted for women than men, with a similar time of maintaining power in both groups. This is evidence of women’s better anaerobic endurance compared to men. At the same time, the men had significantly better starting speed rates than women

Effect of creatine malate supplementation on physical performance, body composition and selected hormone levels in spinters and long-distance runners

Purpose The aim of the study was to determine whether creatine malate (CML) supplementation results in similar ergogenic effect in sprinters and long-distance runners. The other goal was to compare changes in body composition, physical performance and hormone levels after six-week training in athletes, divided into subgroups supplemented with creatine malate or taking placebo. Results Six-week supplementation combined with physical training induced different effects in athletes. Significantly higher increases in relative and absolute peak power and total work (p < 0.05) were found in sprinters compared to other groups. Except for growth hormone, post-exercise venous blood serum hormone levels exhibited no statistically significant differences in athletes. After CML loading period, a significant increase in growth hormone was found in the group of sprinters. Conclusions A significant ergogenic effect was found in sprinters, which was reflected by the increase in anaerobic exercise indices and morphological indices and elevated growth hormone level, after graded exercise testing. The significant increase in the distance covered during graded test was only observed in supplemented long-distance runners, whereas no significant changes in maximal oxygen uptake, relative peak power and relative total work were noticed. This could be caused by later anaerobic threshold appearance in exercise test to exhaustion

Energy expenditure and physiological responses during walking on a treadmill and moving on the Torqway vehicle

Purpose: One of the new products which can be used to increase physical activity and energy expenditure is the Torqway vehicle, powered by the upper limbs. The aim of this study was to (1) assess the usefulness and repeatability of the Torqway vehicle for physical exercise, (2) compare energy expenditure and physiological responses during walking on a treadmill and during physical effort while moving on the Torqway at a constant speed. Methods: The participants (11 men, aged 20.2 ± 1.3) performed the incremental test and submaximal exercises (walking on the treadmill and moving on the Torqway vehicle at the same speed). Results: Energy expenditure during the exercise on the Torqway was significantly higher (p = 0.001) than during the walking performed at the same speed. The intensity of the exercise performed on the Torqway expressed as %VO2max and %HRmax was significantly ( p < 0.001) higher than during walking (respectively: 35.0 ± 6.0 vs. 29.4 ± 7.4 %VO2max and 65.1 ± 7.3 vs. 47.2 ± 7.4 %HRmax). Conclusions: Exercise on the Torqway vehicle allows for the intensification of the exercise at a low movement speed, comparable to walking. Moving on the Torqway vehicle could be an effective alternative activity for physical fitness and exercise rehabilitation programs

NO ASSOCIATION BETWEEN tHbmass AND POLYMORPHISMS IN THE HBB GENE IN ENDURANCE ATHLETES

The aim of this study was to examine the association between tHbmass and HBB gene polymorphisms in athletes of endurance disciplines. Eighty-two well-trained athletes (female n=36, male n=46), aged 19.3 ± 2.7 years, representing cross country skiing (n=37) and middle- and long-distance running (n=45), participated in the study. Genotyping for 2 polymorphisms in the HBB gene (- 551C/T and intron 2, +16 C/G) was performed using restriction fragment length polymorphism analysis. Total haemoglobin mass (tHbmass) was determined by the optimized carbon monoxide rebreathing method. Blood morphology, indices of iron status (ferritin, transferrin receptor and total iron binding capacity) and C reactive protein were also determined. No differences were found in the HBB genotype and allele frequencies between male and female athletes. Regardless of the polymorphisms, no relationships were found between HBB genotypes as well as alleles and relative values of tHbmass, expressed per body mass (g · kg-1 BM), both in female and male athletes. Our results demonstrated that -551 C/T and intron 2, +16 C/G polymorphisms of the HBB gene have no association with total haemoglobin mass in endurance athletes. It cannot be ruled out that several polymorphisms, each with a small but significant contribution, may be responsible for the amount of haemoglobin

Results and recommendations of the 7th European Hypoxia Symposium 2014

One of the main themes of the 7th European Hypoxia Symposium 2014 in Berchtesgaden, Germany was \u201eContraindications for Exposure to Hypoxia\u201c. In this paper, we summarize the statements and recommendations for high-altitude sojourns with pre-existing medical conditions. Exposure to altitude is increasingly common even amongst elderly people. Therefore, the number of persons with pre-existing medical conditions is rising, as is the number of physicians\u2019 consultations prior to a planned high-altitude sojourn. For persons with no previous altitude experience, risk assessment is difficult, because the most reliable predicting factor for developing high-altitude-related disease is previous episodes in the patients\u2019 medical history. Risk assessment in clinical practice should start with a clinical examination and evaluation of any cardiopulmonary diseases that could worsen at high altitude. The fundamental question is: \u201cWill the pre-existing condition aggravate during the high-altitude stay or can it compromise the safety of the patient respectively his partner?\u201d Consensus: In general, even for people with pre-existing conditions, high-altitude sojourns (>2500m) should be possible, provided fundamental recommendations of acclimatization are followed. People with severe pre-existing conditions should avoid sojourns at extreme altitudes particularly when they have no or little experience in these environments. UIAA guidelines have been developed to assist physicians without high-altitude expertise to give advice in uncomplicated cases. In complex cases or severe pre-existing conditions, advice of a physician with expertise in high-altitude (and travel) medicine should be sought to assess specific individual risks